Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer—results from the randomized phase III SUCCESS-A trial
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Erlangen ; Nürnberg
Friedrich-Alexander-Universität Erlangen-Nürnberg
2022
|
| Schlagworte: | |
| Online-Zugang: | kostenfrei kostenfrei |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV048206439 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 220510s2022 gw o|||| 00||| eng d | ||
| 016 | 7 | |a 122296483X |2 DE-101 | |
| 024 | 7 | |a urn:nbn:de:bvb:29-opus4-180751 |2 urn | |
| 035 | |a (OCoLC)1317697392 | ||
| 035 | |a (DE-599)DNB122296483X | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |8 3\p |a eng | |
| 044 | |a gw |c XA-DE | ||
| 049 | |a DE-29 | ||
| 050 | 0 | |a RC261-271 |2 lcc | |
| 084 | |8 2\p |a 610 |2 23sdnb | ||
| 084 | |8 1\p |a 616.994 |2 23ksdnb | ||
| 100 | 1 | |a Gregorio, Amelie de |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer—results from the randomized phase III SUCCESS-A trial |c by Amelie de Gregorio, Lothar Häberle, Peter A. Fasching, Volkmar Müller, Iris Schrader, Ralf Lorenz, Helmut Forstbauer, Thomas W. P. Friedl, Emanuel Bauer, Nikolaus de Gregorio, Miriam Deniz, Visnja Fink, Inga Bekes, Ulrich Andergassen, Andreas Schneeweiss, Hans Tesch, Sven Mahner, Sara Y. Brucker, Jens-Uwe Blohmer, Tanja N. Fehm, Georg Heinrich, Krisztian Lato, Matthias W. Beckmann, Brigitte Rack, Wolfgang Janni |
| 264 | 1 | |a Erlangen ; Nürnberg |b Friedrich-Alexander-Universität Erlangen-Nürnberg |c 2022 | |
| 300 | |a 1 Online-Ressource | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 650 | 0 | |a Cancer research. | |
| 650 | 0 | |a Oncology. | |
| 650 | 0 | |a Surgical oncology. | |
| 653 | |a Cancer Research. | ||
| 653 | |a Oncology. | ||
| 653 | |a Surgical Oncology. | ||
| 700 | 1 | |a Häberle, Lothar |e Verfasser |4 aut | |
| 700 | 1 | |a Fasching, Peter A. |e Verfasser |4 aut | |
| 700 | 1 | |a Müller, Volkmar |e Verfasser |4 aut | |
| 700 | 1 | |a Schrader, Iris |e Verfasser |4 aut | |
| 700 | 1 | |a Lorenz, Ralf |e Verfasser |4 aut | |
| 700 | 1 | |a Forstbauer, Helmut |e Verfasser |4 aut | |
| 700 | 1 | |a Friedl, Thomas W. P. |e Verfasser |4 aut | |
| 700 | 1 | |a Bauer, Emanuel |e Verfasser |4 aut | |
| 700 | 1 | |a Gregorio, Nikolaus de |e Verfasser |4 aut | |
| 700 | 1 | |a Deniz, Miriam |e Verfasser |4 aut | |
| 700 | 1 | |a Fink, Visnja |e Verfasser |4 aut | |
| 700 | 1 | |a Bekes, Inga |e Verfasser |4 aut | |
| 700 | 1 | |a Andergassen, Ulrich |e Verfasser |4 aut | |
| 700 | 1 | |a Schneeweiss, Andreas |e Verfasser |4 aut | |
| 700 | 1 | |a Tesch, Hans |e Verfasser |4 aut | |
| 700 | 1 | |a Mahner, Sven |e Verfasser |4 aut | |
| 700 | 1 | |a Brucker, Sara Y. |e Verfasser |4 aut | |
| 700 | 1 | |a Blohmer, Jens-Uwe |e Verfasser |4 aut | |
| 700 | 1 | |a Fehm, Tanja N. |e Verfasser |4 aut | |
| 700 | 1 | |a Heinrich, Georg |e Verfasser |4 aut | |
| 700 | 1 | |a Lato, Krisztian |e Verfasser |4 aut | |
| 700 | 1 | |a Beckmann, Matthias W. |e Verfasser |4 aut | |
| 700 | 1 | |a Rack, Brigitte |e Verfasser |4 aut | |
| 700 | 1 | |a Janni, Wolfgang |e Verfasser |4 aut | |
| 787 | 0 | 8 | |i Sonderdruck aus |t Breast Cancer Research |g 22 (2020), 111 |o 10.1186/s13058-020-01348-w |
| 856 | 4 | 0 | |u https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-180751 |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://open.fau.de/handle/openfau/18075 |x Verlag |z kostenfrei |3 Volltext |
| 912 | |a ebook | ||
| 883 | 0 | |8 1\p |a aepkn |c 0,99983 |d 20201208 |q DE-101 |u https://d-nb.info/provenance/plan#aepkn | |
| 883 | 0 | |8 2\p |a aepsg |c 0,99984 |d 20201208 |q DE-101 |u https://d-nb.info/provenance/plan#aepsg | |
| 883 | 1 | |8 3\p |a npi |d 20201207 |q DE-101 |u https://d-nb.info/provenance/plan#npi | |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-033587324 | |
Datensatz im Suchindex
| _version_ | 1819313039404433408 |
|---|---|
| any_adam_object | |
| author | Gregorio, Amelie de Häberle, Lothar Fasching, Peter A. Müller, Volkmar Schrader, Iris Lorenz, Ralf Forstbauer, Helmut Friedl, Thomas W. P. Bauer, Emanuel Gregorio, Nikolaus de Deniz, Miriam Fink, Visnja Bekes, Inga Andergassen, Ulrich Schneeweiss, Andreas Tesch, Hans Mahner, Sven Brucker, Sara Y. Blohmer, Jens-Uwe Fehm, Tanja N. Heinrich, Georg Lato, Krisztian Beckmann, Matthias W. Rack, Brigitte Janni, Wolfgang |
| author_facet | Gregorio, Amelie de Häberle, Lothar Fasching, Peter A. Müller, Volkmar Schrader, Iris Lorenz, Ralf Forstbauer, Helmut Friedl, Thomas W. P. Bauer, Emanuel Gregorio, Nikolaus de Deniz, Miriam Fink, Visnja Bekes, Inga Andergassen, Ulrich Schneeweiss, Andreas Tesch, Hans Mahner, Sven Brucker, Sara Y. Blohmer, Jens-Uwe Fehm, Tanja N. Heinrich, Georg Lato, Krisztian Beckmann, Matthias W. Rack, Brigitte Janni, Wolfgang |
| author_role | aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut |
| author_sort | Gregorio, Amelie de |
| author_variant | a d g ad adg l h lh p a f pa paf v m vm i s is r l rl h f hf t w p f twp twpf e b eb n d g nd ndg m d md v f vf i b ib u a ua a s as h t ht s m sm s y b sy syb j u b jub t n f tn tnf g h gh k l kl m w b mw mwb b r br w j wj |
| building | Verbundindex |
| bvnumber | BV048206439 |
| callnumber-first | R - Medicine |
| callnumber-label | RC261-271 |
| callnumber-raw | RC261-271 |
| callnumber-search | RC261-271 |
| callnumber-sort | RC 3261 3271 |
| callnumber-subject | RC - Internal Medicine |
| collection | ebook |
| ctrlnum | (OCoLC)1317697392 (DE-599)DNB122296483X |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03397nam a2200757zc 4500</leader><controlfield tag="001">BV048206439</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">220510s2022 gw o|||| 00||| eng d</controlfield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">122296483X</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">urn:nbn:de:bvb:29-opus4-180751</subfield><subfield code="2">urn</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1317697392</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB122296483X</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC261-271</subfield><subfield code="2">lcc</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="8">2\p</subfield><subfield code="a">610</subfield><subfield code="2">23sdnb</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="8">1\p</subfield><subfield code="a">616.994</subfield><subfield code="2">23ksdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Gregorio, Amelie de</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer—results from the randomized phase III SUCCESS-A trial</subfield><subfield code="c">by Amelie de Gregorio, Lothar Häberle, Peter A. Fasching, Volkmar Müller, Iris Schrader, Ralf Lorenz, Helmut Forstbauer, Thomas W. P. Friedl, Emanuel Bauer, Nikolaus de Gregorio, Miriam Deniz, Visnja Fink, Inga Bekes, Ulrich Andergassen, Andreas Schneeweiss, Hans Tesch, Sven Mahner, Sara Y. Brucker, Jens-Uwe Blohmer, Tanja N. Fehm, Georg Heinrich, Krisztian Lato, Matthias W. Beckmann, Brigitte Rack, Wolfgang Janni</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Erlangen ; Nürnberg</subfield><subfield code="b">Friedrich-Alexander-Universität Erlangen-Nürnberg</subfield><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cancer research.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Oncology.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Surgical oncology.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Cancer Research.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Oncology.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Surgical Oncology.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Häberle, Lothar</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fasching, Peter A.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Müller, Volkmar</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schrader, Iris</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lorenz, Ralf</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Forstbauer, Helmut</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Friedl, Thomas W. P.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bauer, Emanuel</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gregorio, Nikolaus de</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Deniz, Miriam</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fink, Visnja</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bekes, Inga</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Andergassen, Ulrich</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schneeweiss, Andreas</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tesch, Hans</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mahner, Sven</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brucker, Sara Y.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Blohmer, Jens-Uwe</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fehm, Tanja N.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Heinrich, Georg</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lato, Krisztian</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Beckmann, Matthias W.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rack, Brigitte</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Janni, Wolfgang</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="787" ind1="0" ind2="8"><subfield code="i">Sonderdruck aus</subfield><subfield code="t">Breast Cancer Research</subfield><subfield code="g">22 (2020), 111</subfield><subfield code="o">10.1186/s13058-020-01348-w</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-180751</subfield><subfield code="x">Resolving-System</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://open.fau.de/handle/openfau/18075</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ebook</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">aepkn</subfield><subfield code="c">0,99983</subfield><subfield code="d">20201208</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#aepkn</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">aepsg</subfield><subfield code="c">0,99984</subfield><subfield code="d">20201208</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#aepsg</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">npi</subfield><subfield code="d">20201207</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#npi</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-033587324</subfield></datafield></record></collection> |
| id | DE-604.BV048206439 |
| illustrated | Not Illustrated |
| indexdate | 2024-12-24T09:21:59Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-033587324 |
| oclc_num | 1317697392 |
| open_access_boolean | 1 |
| owner | DE-29 |
| owner_facet | DE-29 |
| physical | 1 Online-Ressource |
| psigel | ebook |
| publishDate | 2022 |
| publishDateSearch | 2022 |
| publishDateSort | 2022 |
| publisher | Friedrich-Alexander-Universität Erlangen-Nürnberg |
| record_format | marc |
| spelling | Gregorio, Amelie de Verfasser aut Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer—results from the randomized phase III SUCCESS-A trial by Amelie de Gregorio, Lothar Häberle, Peter A. Fasching, Volkmar Müller, Iris Schrader, Ralf Lorenz, Helmut Forstbauer, Thomas W. P. Friedl, Emanuel Bauer, Nikolaus de Gregorio, Miriam Deniz, Visnja Fink, Inga Bekes, Ulrich Andergassen, Andreas Schneeweiss, Hans Tesch, Sven Mahner, Sara Y. Brucker, Jens-Uwe Blohmer, Tanja N. Fehm, Georg Heinrich, Krisztian Lato, Matthias W. Beckmann, Brigitte Rack, Wolfgang Janni Erlangen ; Nürnberg Friedrich-Alexander-Universität Erlangen-Nürnberg 2022 1 Online-Ressource txt rdacontent c rdamedia cr rdacarrier Cancer research. Oncology. Surgical oncology. Cancer Research. Surgical Oncology. Häberle, Lothar Verfasser aut Fasching, Peter A. Verfasser aut Müller, Volkmar Verfasser aut Schrader, Iris Verfasser aut Lorenz, Ralf Verfasser aut Forstbauer, Helmut Verfasser aut Friedl, Thomas W. P. Verfasser aut Bauer, Emanuel Verfasser aut Gregorio, Nikolaus de Verfasser aut Deniz, Miriam Verfasser aut Fink, Visnja Verfasser aut Bekes, Inga Verfasser aut Andergassen, Ulrich Verfasser aut Schneeweiss, Andreas Verfasser aut Tesch, Hans Verfasser aut Mahner, Sven Verfasser aut Brucker, Sara Y. Verfasser aut Blohmer, Jens-Uwe Verfasser aut Fehm, Tanja N. Verfasser aut Heinrich, Georg Verfasser aut Lato, Krisztian Verfasser aut Beckmann, Matthias W. Verfasser aut Rack, Brigitte Verfasser aut Janni, Wolfgang Verfasser aut Sonderdruck aus Breast Cancer Research 22 (2020), 111 10.1186/s13058-020-01348-w https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-180751 Resolving-System kostenfrei Volltext https://open.fau.de/handle/openfau/18075 Verlag kostenfrei Volltext 1\p aepkn 0,99983 20201208 DE-101 https://d-nb.info/provenance/plan#aepkn 2\p aepsg 0,99984 20201208 DE-101 https://d-nb.info/provenance/plan#aepsg 3\p npi 20201207 DE-101 https://d-nb.info/provenance/plan#npi |
| spellingShingle | Gregorio, Amelie de Häberle, Lothar Fasching, Peter A. Müller, Volkmar Schrader, Iris Lorenz, Ralf Forstbauer, Helmut Friedl, Thomas W. P. Bauer, Emanuel Gregorio, Nikolaus de Deniz, Miriam Fink, Visnja Bekes, Inga Andergassen, Ulrich Schneeweiss, Andreas Tesch, Hans Mahner, Sven Brucker, Sara Y. Blohmer, Jens-Uwe Fehm, Tanja N. Heinrich, Georg Lato, Krisztian Beckmann, Matthias W. Rack, Brigitte Janni, Wolfgang Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer—results from the randomized phase III SUCCESS-A trial Cancer research. Oncology. Surgical oncology. |
| title | Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer—results from the randomized phase III SUCCESS-A trial |
| title_auth | Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer—results from the randomized phase III SUCCESS-A trial |
| title_exact_search | Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer—results from the randomized phase III SUCCESS-A trial |
| title_full | Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer—results from the randomized phase III SUCCESS-A trial by Amelie de Gregorio, Lothar Häberle, Peter A. Fasching, Volkmar Müller, Iris Schrader, Ralf Lorenz, Helmut Forstbauer, Thomas W. P. Friedl, Emanuel Bauer, Nikolaus de Gregorio, Miriam Deniz, Visnja Fink, Inga Bekes, Ulrich Andergassen, Andreas Schneeweiss, Hans Tesch, Sven Mahner, Sara Y. Brucker, Jens-Uwe Blohmer, Tanja N. Fehm, Georg Heinrich, Krisztian Lato, Matthias W. Beckmann, Brigitte Rack, Wolfgang Janni |
| title_fullStr | Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer—results from the randomized phase III SUCCESS-A trial by Amelie de Gregorio, Lothar Häberle, Peter A. Fasching, Volkmar Müller, Iris Schrader, Ralf Lorenz, Helmut Forstbauer, Thomas W. P. Friedl, Emanuel Bauer, Nikolaus de Gregorio, Miriam Deniz, Visnja Fink, Inga Bekes, Ulrich Andergassen, Andreas Schneeweiss, Hans Tesch, Sven Mahner, Sara Y. Brucker, Jens-Uwe Blohmer, Tanja N. Fehm, Georg Heinrich, Krisztian Lato, Matthias W. Beckmann, Brigitte Rack, Wolfgang Janni |
| title_full_unstemmed | Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer—results from the randomized phase III SUCCESS-A trial by Amelie de Gregorio, Lothar Häberle, Peter A. Fasching, Volkmar Müller, Iris Schrader, Ralf Lorenz, Helmut Forstbauer, Thomas W. P. Friedl, Emanuel Bauer, Nikolaus de Gregorio, Miriam Deniz, Visnja Fink, Inga Bekes, Ulrich Andergassen, Andreas Schneeweiss, Hans Tesch, Sven Mahner, Sara Y. Brucker, Jens-Uwe Blohmer, Tanja N. Fehm, Georg Heinrich, Krisztian Lato, Matthias W. Beckmann, Brigitte Rack, Wolfgang Janni |
| title_short | Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer—results from the randomized phase III SUCCESS-A trial |
| title_sort | gemcitabine as adjuvant chemotherapy in patients with high risk early breast cancer results from the randomized phase iii success a trial |
| topic | Cancer research. Oncology. Surgical oncology. |
| topic_facet | Cancer research. Oncology. Surgical oncology. |
| url | https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-180751 https://open.fau.de/handle/openfau/18075 |
| work_keys_str_mv | AT gregorioameliede gemcitabineasadjuvantchemotherapyinpatientswithhighriskearlybreastcancerresultsfromtherandomizedphaseiiisuccessatrial AT haberlelothar gemcitabineasadjuvantchemotherapyinpatientswithhighriskearlybreastcancerresultsfromtherandomizedphaseiiisuccessatrial AT faschingpetera gemcitabineasadjuvantchemotherapyinpatientswithhighriskearlybreastcancerresultsfromtherandomizedphaseiiisuccessatrial AT mullervolkmar gemcitabineasadjuvantchemotherapyinpatientswithhighriskearlybreastcancerresultsfromtherandomizedphaseiiisuccessatrial AT schraderiris gemcitabineasadjuvantchemotherapyinpatientswithhighriskearlybreastcancerresultsfromtherandomizedphaseiiisuccessatrial AT lorenzralf gemcitabineasadjuvantchemotherapyinpatientswithhighriskearlybreastcancerresultsfromtherandomizedphaseiiisuccessatrial AT forstbauerhelmut gemcitabineasadjuvantchemotherapyinpatientswithhighriskearlybreastcancerresultsfromtherandomizedphaseiiisuccessatrial AT friedlthomaswp gemcitabineasadjuvantchemotherapyinpatientswithhighriskearlybreastcancerresultsfromtherandomizedphaseiiisuccessatrial AT baueremanuel gemcitabineasadjuvantchemotherapyinpatientswithhighriskearlybreastcancerresultsfromtherandomizedphaseiiisuccessatrial AT gregorionikolausde gemcitabineasadjuvantchemotherapyinpatientswithhighriskearlybreastcancerresultsfromtherandomizedphaseiiisuccessatrial AT denizmiriam gemcitabineasadjuvantchemotherapyinpatientswithhighriskearlybreastcancerresultsfromtherandomizedphaseiiisuccessatrial AT finkvisnja gemcitabineasadjuvantchemotherapyinpatientswithhighriskearlybreastcancerresultsfromtherandomizedphaseiiisuccessatrial AT bekesinga gemcitabineasadjuvantchemotherapyinpatientswithhighriskearlybreastcancerresultsfromtherandomizedphaseiiisuccessatrial AT andergassenulrich gemcitabineasadjuvantchemotherapyinpatientswithhighriskearlybreastcancerresultsfromtherandomizedphaseiiisuccessatrial AT schneeweissandreas gemcitabineasadjuvantchemotherapyinpatientswithhighriskearlybreastcancerresultsfromtherandomizedphaseiiisuccessatrial AT teschhans gemcitabineasadjuvantchemotherapyinpatientswithhighriskearlybreastcancerresultsfromtherandomizedphaseiiisuccessatrial AT mahnersven gemcitabineasadjuvantchemotherapyinpatientswithhighriskearlybreastcancerresultsfromtherandomizedphaseiiisuccessatrial AT bruckersaray gemcitabineasadjuvantchemotherapyinpatientswithhighriskearlybreastcancerresultsfromtherandomizedphaseiiisuccessatrial AT blohmerjensuwe gemcitabineasadjuvantchemotherapyinpatientswithhighriskearlybreastcancerresultsfromtherandomizedphaseiiisuccessatrial AT fehmtanjan gemcitabineasadjuvantchemotherapyinpatientswithhighriskearlybreastcancerresultsfromtherandomizedphaseiiisuccessatrial AT heinrichgeorg gemcitabineasadjuvantchemotherapyinpatientswithhighriskearlybreastcancerresultsfromtherandomizedphaseiiisuccessatrial AT latokrisztian gemcitabineasadjuvantchemotherapyinpatientswithhighriskearlybreastcancerresultsfromtherandomizedphaseiiisuccessatrial AT beckmannmatthiasw gemcitabineasadjuvantchemotherapyinpatientswithhighriskearlybreastcancerresultsfromtherandomizedphaseiiisuccessatrial AT rackbrigitte gemcitabineasadjuvantchemotherapyinpatientswithhighriskearlybreastcancerresultsfromtherandomizedphaseiiisuccessatrial AT janniwolfgang gemcitabineasadjuvantchemotherapyinpatientswithhighriskearlybreastcancerresultsfromtherandomizedphaseiiisuccessatrial |